Localized Infusion News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Localized Infusion. Real-time updates on events, politics, business and more.

Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the ...

April 24, 2024

Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical data

United States North Carolina Duke University Western Australia Superkine Immunotherapies John Sampson

Source: eagletribune.com

Medicenna Therapeutics Corp. Announces A Poster Presentation and an Oral Summary Highlighting Long-term Follow-up Up Results from the Phase 2b Clinical Trial of Bizaxofusp

November 18, 2023

Medicenna Therapeutics Corp. announced that a poster presentation and an oral summary highlighting longer term follow up results from the Phase 2b clinical trial of bizaxofusp , the Companys...

British Columbia Steven Brem Centre For Precision Surgery Society For Neuro Abramson Cancer Center Perelman School Of Medicine

Source: marketscreener.com

Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp

November 9, 2023

TORONTO and HOUSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTC: MDNAF), a...

United States University Of Pennsylvania British Columbia Steven Brem Christina Cameron Superkine Immunotherapies

Source: globenewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Localized Infusion News Today

Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the ...

Medicenna Therapeutics Corp. Announces A Poster Presentation and an Oral Summary Highlighting Long-term Follow-up Up Results from the Phase 2b Clinical Trial of Bizaxofusp

Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp

Explore More Categories